Advertisement
News
Advertisement

Sarepta’s treatment for Ebola, other viruses hit FDA fast track

Tue, 09/18/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Sarepta Therapeutics Inc. (Nasdaq: SRPT) says it’s been granted fast-track status for two of its potential drugs to treat bioweapons, the Ebola virus and the Marburg virus, according to a statement.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading